U.S. flag

An official website of the United States government

NM_003742.4(ABCB11):c.3169C>T (p.Arg1057Ter) AND Progressive familial intrahepatic cholestasis type 2

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Nov 2, 2017
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000006975.4

Allele description [Variation Report for NM_003742.4(ABCB11):c.3169C>T (p.Arg1057Ter)]

NM_003742.4(ABCB11):c.3169C>T (p.Arg1057Ter)

Gene:
ABCB11:ATP binding cassette subfamily B member 11 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q31.1
Genomic location:
Preferred name:
NM_003742.4(ABCB11):c.3169C>T (p.Arg1057Ter)
HGVS:
  • NC_000002.12:g.168932421G>A
  • NG_007374.2:g.103976C>T
  • NM_003742.4:c.3169C>TMANE SELECT
  • NP_003733.2:p.Arg1057Ter
  • LRG_1199t1:c.3169C>T
  • LRG_1199:g.103976C>T
  • LRG_1199p1:p.Arg1057Ter
  • NC_000002.11:g.169788931G>A
  • NG_007374.1:g.103903C>T
  • NM_003742.2:c.3169C>T
Protein change:
R1057*; ARG1057TER
Links:
OMIM: 603201.0007; dbSNP: rs72549397
NCBI 1000 Genomes Browser:
rs72549397
Molecular consequence:
  • NM_003742.4:c.3169C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Progressive familial intrahepatic cholestasis type 2
Identifiers:
MONDO: MONDO:0011156; MedGen: C3489789; Orphanet: 79304; OMIM: 601847

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000027171OMIM
no assertion criteria provided
Pathogenic
(Dec 1, 1999)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV002077888Natera, Inc.
no assertion criteria provided
Pathogenic
(Nov 2, 2017)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.

Jansen PL, Strautnieks SS, Jacquemin E, Hadchouel M, Sokal EM, Hooiveld GJ, Koning JH, De Jager-Krikken A, Kuipers F, Stellaard F, Bijleveld CM, Gouw A, Van Goor H, Thompson RJ, Müller M.

Gastroenterology. 1999 Dec;117(6):1370-9.

PubMed [citation]
PMID:
10579978

Details of each submission

From OMIM, SCV000027171.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a patient with progressive familial intrahepatic cholestasis (PFIC2; 601847), Jansen et al. (1999) identified compound heterozygosity for 2 mutations in the ABCB11 gene: arg1057-to-ter (R1057X) and E297G (603201.0002). Immunohistochemistry showed absence of the BSEP protein in liver.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV002077888.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024